Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07508059 · ClinicalTrials.gov registry record · NA

High Resolution Pharyngeal Manometry (HRPM) Biofeedback

A NA study, sponsored by NYU Langone Health.

Not yet
Registry status
NA
Development phase
50
Enrollment target

NCT07508059: Clinical Trial NA study, sponsored by NYU Langone Health.

NCT07508059 is a NA study that has not yet begun recruiting, run by NYU Langone Health. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07508059, a NA study, has not yet begun recruiting, sponsored by NYU Langone Health.

NOT YET RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

The purpose of this study is to quantify the added benefit of visual biofeedback from High Resolution Pharyngeal Manometry (HRPM) for swallowing rehabilitation. Primary aims including assessing changes in swallowing biomechanics (pressure generation, timing) during swallow maneuvers with and without HRPM visual biofeedback. Secondary aim includes participant attitudes related to visual biofeedback and the experience of HRPM.

Primary Outcome

Pharyngeal contractile integral, a product of mean pharyngeal contractile amplitude, length, and duration. Low PhCI (\< 100-150 mmHg·s·cm): Indicates hypo-contractility or weakness while High PhCI (\> 200-300+ mmHg·s·cm): Represents stronger contraction strength

Interventions

  • OTHER Swallowing Maneuvers
  • DIAGNOSTIC_TEST High Resolution Pharyngeal Manometry (HRPM)

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2026-05-01
Est. Completion 2027-05-01
Phase NA
NYU Langone Health

1,164 total trials

What is known before NCT07508059 opens enrollment

NCT07508059 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which Swallowing Maneuvers is the first listed.

NCT07508059 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07508059 about?

NCT07508059 is a clinical study titled "High Resolution Pharyngeal Manometry (HRPM) Biofeedback". The purpose of this study is to quantify the added benefit of visual biofeedback from High Resolution Pharyngeal Manometry (HRPM) for swallowing rehabilitation. Primary aims including assessing changes in swallowing biomechanics (pressure generation, timing) during swallow maneuvers with and without...

What is the current status of trial NCT07508059?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-05-01. Estimated completion is 2027-05-01.

What interventions are being tested in trial NCT07508059?

The interventions under investigation include: Swallowing Maneuvers (OTHER), High Resolution Pharyngeal Manometry (HRPM) (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT07508059?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07508059's enrollment target sits among peer trials

50 1279th of 2000 higher than 622 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07508059, the US trial registry maintained by the National Library of Medicine. NCT07508059 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.